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The Fbw7 tumor suppressor gene encodes the substrate recognition subunit of the SCF ubiquitin
ligase, which targets for degradation a range of oncogenic proteins in a phosphorylation-dependent
manner. Substrate phosphorylation is thought to be the main mechanism that ensures timely
destruction of Fbw7 substrates. We show here that PI3K dependent phosphorylation of Fbw7 stim-
ulates its ability to ubiquitinate and degrade its substrates. Mutation of the phosphorylation site
destabilizes Fbw7 and attenuates degradation of cyclin E and Myc leading to the enhanced expres-
sion of a subset of Myc target genes. We suggest that PI3K-dependent phosphorylation of Fbw7 con-
trols the balance between turnover of Fbw7 and its substrates to ﬁne-tune their activity.
Structured summary of protein interactions:
Fbw7 physically interacts with Fbw7 by anti tag coimmunoprecipitation (View interaction)
Fbw7 physically interacts with SKP1 by anti tag coimmunoprecipitation (View interaction)
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Fbw7/hCdc4 protein is a substrate recognition component of
the SCF ubiquitin ligase [1]. Fbw7 is conserved from yeast to mam-
mals and binds its substrates via a speciﬁc phosphorylated se-
quence motif termed CPD (Cdc4 phospho-degron). Fbw7
recognizes the CPD via a beta-propeller domain, which is formed
by eight WD40 repeats [2]. The F-box domain of Fbw7 recruits
the Skp1-Cullin1-Rbx1 module to mediate efﬁcient ubiquitination
of its substrates, targeting them for degradation by the protea-
some. Via its D-domain Fbw7 forms homodimers, which allows it
to target substrates with low-afﬁnity CPDs and access a wider rep-
ertoire of substrate’s lysines [3]. The Fbw7-mediated ubiquitina-
tion of some substrates can be antagonized by the Usp28
deubiquitinating enzyme, which interacts with Fbw7 and stabilizes
Myc and cyclin E in human tumor cells [4].
The three isoforms of Fbw7 encoded in the mammalian genome
– alpha, beta and gamma – differ in the subcellular localization andchemical Societies. Published by E
CPD, Cdc4 phospho-degron;
l sorting
rzburg.de (N. Popov).are nucleoplasmic, cytoplasmic and nucleolar, respectively [2]. The
alpha isoform is most abundant and is alone sufﬁcient for degrada-
tion of some tested substrates, although there is evidence for coop-
erative action of alpha and gamma isoforms [5,6].
Several targets of Fbw7 are oncoproteins. Consistently, Fbw7 is
encoded by a tumor suppressor gene that is mutated in
approximately 6% of all human cancers. Three mutational hotspots
are in arginines located within the propeller domain that directly
contact conserved CPD residues [7].
The most common mechanism that controls destruction of
Fbw7 substrates is phosphorylation of the CPD motifs [2], but the
activity of Fbw7 can also be regulated posttranslationally. For in-
stance, the association with Usp28 is disrupted in response to
DNA damage leading to the enhanced degradation of Myc [8]. Also,
Fbw7alpha can be phosphorylated by the PKC kinase and this reg-
ulates its nuclear localization [9]. Furthermore, Fbw7 is a target of
the SGK1 kinase and phosphorylation by SGK1 is required for reg-
ulation of Notch signaling [10].
Here, we show that the Fbw7alpha isoform (hereafter referred
to as Fbw7) is phosphorylated at S227 in a PI3K-dependent man-
ner. The phosphorylation attenuates turnover of Fbw7 itself but
promotes ubiquitination of c-Myc and cyclin E. Furthermore, the
S227A mutant Fbw7 is compromised in its ability to regulate
expression of certain Myc target genes, suggesting that PI3K-
dependent phosphorylation controls Fbw7 to precisely adjust its
substrate levels and their activity.lsevier B.V. All rights reserved.
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2.1. Cell culture and chemicals
HCT116, HCT116 Fbw7/, HEK293 and HeLa cells were cul-
tured in DMEM, supplemented with 10% FBS and penicillin/
streptomycin.
Where indicated cells were treated with BEZ235 (LC Laborato-
ries), LY290024, MG-132 (Calbiochem), cycloheximide or N-ethyl-
maleimide (NEM) (Sigma) for the indicated times.
2.2. Plasmids and antibodies
Myc-tagged cyclin E and FLAG-tagged Fbw7alpha expression
vectors were a kind gift from B. Clurman. Site-directed mutagene-
sis was performed to obtain the S227A mutant of Fbw7 and the
correct mutation was conﬁrmed by sequencing. HA-tagged Skp1
expression vector has been described previously [4]. The following
antibodies were used: anti-FLAG M2 (Sigma), anti-phospho-Akt
substrate, anti-phospho-Myc, anti-mTOR (Cell Signaling), anti-c-
Myc C-33, anti-c-Myc 9E10, anti-Cdk2 M-20, anti-Mcl1, anti-cyclin
E (HE12), anti-SREBP1 (Santa-Cruz), anti-HA (Covance).
2.3. Immunoprecipitation and immunoblotting
For immunoprecipitation, cells were lysed in lysis buffer
(20 mM Tris pH 8, 250 mM NaCl, 1% Triton X-100, protease inhib-
itor cocktail (Calbiochem) and phosphatase inhibitors (Sigma)) and
immunoprecipitated with the indicated antibodies and protein
A/G-Sepharose beads. Immunocomplexes were subjected to SDS–
PAGE as described previously [4].
For denaturing immunoprecipitation, cells were resuspended in
equal volumes of PBS and denaturing lysis buffer (2% SDS, 20 mM
EDTA, 50 mMTris pH8), boiled for 5 min at 95 C anddiluted10-fold
in lysis buffer (20 mMTris pH 8, 250 mMNaCl, 1% Triton X-100). Ly-
sates were cleared by centrifugation and immunoprecipitated with
the indicated antibodies andproteinA/G-Sepharosebeads. Immuno-
complexes were subjected to SDS–PAGE as described previously [4].
2.4. Ubiquitination assays
Plasmids encoding Myc, cyclin E, Fbw7, and 6-His-tagged ubiq-
uitin were transiently overexpressed in HeLa cells. 24–48 h after
transfection cells were washed and treated with NEM for 5 min be-
fore lysis. Assays were performed as described previously [4].
2.5. Immunoﬂuorescence
Cells grown on coverslips were ﬁxed with paraformaldehyde,
permeabilized with NP-40 and blocked with FBS and NP-40. Cells
were incubated with the indicated antibodies in 5% FBS–PBS for
45 min at 37 C and slides were mounted with Mowiol.
2.6. FACS
For analysis of the cell cycle proﬁle/distribution, cells were ﬁxed
in ethanol and stained with propidium iodide. Cells were measured
on the Becton Dickinson FACS Canto II instrument and analyzed
with the BD FACS Diva 6.1.2 software.
2.7. RQ PCR
Total RNA was extracted with peqGOLD TriFast reagent (Peqlab)
in accordance with the manufacturer’s instructions and cDNA was
transcribed with random hexanucleotide primers and M-MLV
reverse transcriptase as described. Quantitative PCR was per-formed with Absolute qPCR SYBR Green Mix (Thermo Scientiﬁc)
reagent in accordance with the manufacturer’s instructions on
the MX3000 cycler (Stratagene/Agilent Technologies). Primer
sequences are available upon request.
3. Results
3.1. Fbw7 is phosphorylated in a PI3K-dependent manner at S227
Analysis of the primary amino acid sequence of Fbw7 revealed a
consensus phosphorylation site for the Akt/PKB kinase at S227,
which immediately precedes the D-domain in the common region
of the three Fbw7 isoforms (Fig. 1A). To understand if Fbw7 is
phosphorylated at this site in vivo we expressed FLAG-tagged
Fbw7 in HeLa cells and performed immunoprecipitation with
anti-FLAG antibodies, followed by immunoblotting using an anti-
phospho-Akt substrate antibody. Phosphorylation of wildtype
Fbw7 was readily detected (Fig. 1B). In contrast, the signal was ab-
sent in an immunoprecipitation from vector-transfected cells.
Importantly, mutation of serine 227 to alanine abolished the phos-
pho-speciﬁc signal. A control mutation at Ser182 did not abrogate
reactivity with the anti-phospho-Akt substrate antibody (data not
shown). A reciprocal immunoprecipiation with anti-phospho-Akt
substrate antibody followed by immunoblotting with anti-FLAG
antibodies conﬁrmed these ﬁndings (Fig. 1C). We concluded that
Fbw7 is phosphorylated at S227 in vivo.
Serine 227 is within the sequence RRRIT227S, which conforms to
the consensus site for Akt, mTOR and other AGC family kinases. To
test whether inhibition of PI3K, the key upstream regulator of
these signaling pathways, blocks phosphorylation of Fbw7, HeLa
cells transfected with FLAG-tagged Fbw7 were treated with
LY290024 or BEZ235, two well-characterized inhibitors of PI3K.
Phosphorylation was strongly reduced after a 4-hour treatment
with either compound and was abolished after prolonged expo-
sure, demonstrating that signaling downstream of PI3K is essential
for phosphorylation of serine 227 (Fig. 1C and D).
3.2. S227 phosphorylation of Fbw7 controls the turnover of Fbw7 and
its substrates
To understand the physiological role of S227 phosphorylation,
we transiently expressed Myc and cyclin E with or without Fbw7
proteins in HeLa cells. Co-expression of wildtype, but not of
Fbw7-S227A strongly reduced levels of Myc and cyclin E, suggest-
ing that phosphorylation of S227 is required for full Fbw7 activity
(Fig. 2A). To ascertain that phosphorylation at S227 is instrumental
in controlling the levels of endogenous Fbw7 substrates, we recon-
stituted Fbw7/ HCT116 cells [11] with wildtype Fbw7 or Fbw7-
S227A and analyzed levels of several Fbw7 substrates. Consistent
with previously published data, Fbw7/ cells expressed elevated
levels of cyclin E and Myc and this was rescued by expression of
wildtype Fbw7 (Fig. 2B, [5]). In contrast, Fbw7-S227A was im-
paired in this ability. Levels of other reported substrates of Fbw7,
SREBP1, mTOR and Mcl1 were unaffected in Fbw7-deﬁcient cells
and did not change in response to expression of either Fbw7 pro-
tein (Fig. 2B) [12–15].
Tounderstand if thedifferences inMyc and cyclin Eprotein levels
are due to the effects on protein degradation,wemeasured the turn-
over ofMyc and cyclin E in reconstitutedHCT116 cells after blocking
de novo protein synthesis using cycloheximide. In agreement with
the effects on steady-state levels, turnover of Myc and cyclin E pro-
ceeded more rapidly in cells expressing wildtype Fbw7 compared
to cells expressing Fbw7-S227A. The difference in turnover was
especially apparent for the T58-phosphorylated form of Myc, which
is speciﬁcally recognized by Fbw7. Intriguingly, Fbw7-S227A itself
was less stable than the wildtype protein, suggesting that the re-
Fig. 1. Fbw7 is phosphorylated at S227 in a PI3K-dependent manner. (A) Location of S227 in human Fbw7alpha relative to functional domains. The lower panel shows a
sequence alignment of the Akt consensus site with the S227 motif in Fbw7 orthologs from different species. DD: dimerization domain, shaded area in the alignment represent
the start of DD, phosphorylated serine is boxed. (Hs: Homo sapiens; Mm: Mus musculus; Bt: Bos taurus; Xl: Xenopus laevis; Dr: Danio rerio). (B) HeLa cells were transfected
with FLAG-tagged Fbw7 (WT: wildtype, A: S227A). 48 h after transfection, cells were lysed under denaturing conditions and immunoprecipitated with anti-FLAG antibody.
Immunoprecipitates were analyzed by immunoblotting with anti-phospho-Akt substrate (pAktS) and anti-FLAG antibodies. (C) Experiment was performed as in 1B, but prior
to lysis, cells were treated with 50 lM LY290024 for 4 h and immunoprecipitation was done with anti-phospho-Akt substrate antibody; immunoblot with anti-FLAG
antibody. (D) HeLa cells were transfected as described above. At 24 h after transfection, cells were treated for 4 or 24 h with 1 lM BEZ235 or 50 lM LY290024, then lysed
under denaturing conditions and immunoprecipitated with anti-FLAG antibody. Immunoprecipitates were analyzed by immunoblotting with anti-phospho-Akt substrate and
anti-FLAG antibodies.
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(Fig. 2C). This correlates with lower steady-state levels of Fbw7-
S227A upon stable expression in HCT116 cells (Fig. 2B).
Fbw7 induces degradation of its substrates by promoting their
ubiquitination. Therefore we asked whether S227 phosphorylation
interferes with the ability of Fbw7 to support ubiquitination of c-
Myc and cyclin E in vivo. Expression of wildtype Fbw7, but not of
Fbw7-S227A, promoted efﬁcient ubiquitination of Myc concomi-
tant with a decrease in the levels of the unmodiﬁed Myc protein
(Fig. 2D, left panel). Identical results were obtained for cyclin E
(Fig. 2D, right panel). We concluded that phosphorylation of
Fbw7 at S227 stimulates its ability to promote ubiquitination and
turnover of its substrates.
3.3. Phosphorylation does not affect subcellular localization or known
interactions of Fbw7
We sought to elucidate the molecular basis for the effect of S227
phosphorylation on the function of Fbw7. Different isoforms of
Fbw7 reside in distinct subcellular compartments and even locali-
zation of a single isoform is regulated by interacting proteins
[9,16,17]. To address a potential inﬂuence of S227 phosphorylation
on localization of Fbw7, we performed immunoﬂuorescence anal-
ysis of HeLa cells expressing either wildtype or mutant Fbw7. Both
proteins localized to the nucleoplasm, characteristic of the alpha
isoform (Fig. 3A).Next, we analyzed whether mutation of S227 affects known
molecular interactions of Fbw7. Via its F-Box domain, Fbw7 binds
Skp1, which in turn recruits the Cullin1-Rbx1/2 complex tomediate
ubiquitination of Fbw7 substrates [1]. Using immunoprecipitation
assays, we compared the wildtype and mutant Fbw7 protein for
their ability to interact with Skp1. Both wildtype and S227A Fbw7
mutant efﬁciently recruited Skp1, arguing that the defect in the
ability to promote ubiquitination of the mutant Fbw7 is not due
to deﬁcient Skp1 and SCF recruitment (Fig. 3B).
Fbw7 forms homodimers which is important for the regula-
tion of substrates with low afﬁnity CPDs [3]. To test if phosphor-
ylation at S227 is important for homodimer formation we co-
transfected HA-tagged wildtype Fbw7 with either wildtype or
mutant FLAG-tagged Fbw7 in HeLa cells and analyzed their
interaction using immunoprecipitation. Both wildtype and mu-
tant Fbw7 efﬁciently recruited HA-tagged wildtype Fbw7
(Fig. 3C). In contrast, the dimerization-deﬁcient LI256EE mutant
failed to interact, in agreement with previous observations (data
not shown) [3].
Similar immunoprecipitation experiments revealed that S227
phosphorylation is not essential for binding to Usp28 or substrate
recognition by Fbw7 (data not shown). Taken together, this analy-
sis demonstrated that the known interactions of Fbw7 do not re-
quire PI3K-dependent phosphorylation and the defect in the
ability to promote substrate ubiquitination and degradation origi-
nated from a yet uncharacterized activity of Fbw7.
Fig. 2. S227 phosphorylation of Fbw7 controls the turnover of Fbw7 and its substrates. (A) HeLa cells were transfected with expression vectors encoding Myc or Myc-tagged
cyclin E (MT-cyclin E) and FLAG-tagged Fbw7 (WT: wildtype, A: S227A). At 48 h after transfection, cells were harvested and analyzed by immunoblotting. (B) Fbw7/
HCT116 cells were transduced with retroviruses encoding FLAG-tagged Fbw7 wildtype or the S227A mutant Fbw7 along with a control vector; cells were selected and pools
were analyzed by immunoblotting. Parental HCT116 were run in parallel as a control. (C) Fbw7/ HCT116 cells transduced as in 2B were treated with cycloheximide (CHX;
100 lg ml1) to block protein synthesis and collected at the indicated time points after addition of the drug. Total cell extracts were examined by immunoblotting. (D) HeLa
cells were transfected with expression vectors encoding c-Myc, cyclin E, His-tagged ubiquitin and FLAG-tagged Fbw7. At 48 h after transfection, cells were treated with 1 mM
NEM for 5 min before lysis and ubiquitinated proteins were recovered with Ni2+-NTA resin, followed by immunoblotting with the indicated antibodies.
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Fbw7 is implicated in control of both cell cycle arrest and apop-
tosis [18,19]. To test the role of S227A phosphorylation in Fbw7
function, we have used Fbw7-null HCT116 cells. Under high serum
conditions, neither wildtype nor S227A mutant Fbw7 elicited ma-
jor changes in cell cycle distribution of the reconstituted HCT116
cells (Fig. 4A, left panel). In contrast, serum withdrawal induced
a pronounced apoptotic response in cells expressing wildtype
Fbw7 compared to the Fbw7-null or the S227A mutant-expressing
cells (Fig. 4A, right panel), consistent with a reduced biological
activity of Fbw7-S227A.
To understand how phosphorylation of Fbw7 affects activity of
its substrates, we compared expression of Myc target genes in
Fbw7/ and reconstituted HCT116 cells using RQ PCR. Wildtype
and mutant FBXW7 mRNAs were expressed at comparable levels,suggesting that lower protein levels of the S227A mutant are due
to the decreased protein stability (Fig. 4B, left panel). We found
that while some of the target genes responded identically to either
wildtype or mutant Fbw7, several transcriptional targets of Myc
showed an attenuated response to the mutant protein (Fig. 4B,
right panel). This result suggests that different Myc target genes
are differentially sensitive to Myc levels and that enhanced Fbw7
activity is required to antagonize Myc-dependent regulation on a
subset of its target genes.
4. Discussion
Recent studies have identiﬁed Fbw7 as a target of several ki-
nases. For instance, phosphorylation by the PKC kinase can con-
trol its subcellular localization, while phosphorylation in
response to DNA damage correlates with the enhanced ability
Fig. 3. Phosphorylation does not affect subcellular localization or known interactions of Fbw7. (A) Immunoﬂuorescence analysis was performed on HeLa cells transiently
transfected with FLAG-tagged wildtype Fbw7 or the S227A mutant Fbw7. Transfection efﬁciency in the experiment shown was 20%. Anti-FLAG antibody was used to detect
Fbw7; Hoechst stain was used to visualize the nuclei. (B) HEK293 cells were transfected with expression vectors encoding HA-tagged Skp1 and either FLAG-tagged wildtype
Fbw7 or the S227A mutant Fbw7 as indicated. 48 h after transfection, cells were treated with 10 lM of the proteasome inhibitor MG-132 for 3 h, then lysed and
immunoprecipitated with anti-FLAG antibody. Immunoprecipitates were probed with antibodies directed against FLAG and HA. The input corresponds to 2% of the material
used for the immunoprecipitation. (C) Experiment was performed as in 3B but cells were transfected with HA-tagged Fbw7 wildtype and either FLAG-tagged wildtype Fbw7
or the S227A mutant Fbw7 as indicated.
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get of the PI3K pathway. We show that this modiﬁcation stabi-
lizes Fbw7 and leads to the enhanced ability to ubiquitinate
and degrade two substrates, cyclin E and c-Myc. Consistent with
the biochemical data, we found that the Fbw7 S227A mutant is
compromised in its ability to induce apoptosis in Fbw7-null
HCT116 cells and suppress the transcriptional function of the
Myc oncoprotein, a downstream target of Fbw7. Our data are con-
sistent with a recent report demonstrating that phosphorylation
of S227 by SGK1 is required for efﬁcient degradation of the Notch
protein [10]. SGK1 is a PI3K-dependent kinase and therefore may
account for the effects observed in our study [21]. Alternatively, it
is possible that several additional kinases with similar substrate
speciﬁcity (e.g., Akt and mTOR) directly regulate Fbw7 via S227
phosphorylation. Clearly, further analysis is required to establish
the range of events and effector kinases that contribute to S227
phosphorylation.
Our data raise an interesting mechanistic question – an ac-
cepted view is that F-box proteins mediate their own degradation
when their substrates become unavailable [22]. According to this
model, the less stable S227A mutant should degrade its substrates
more efﬁciently. However, we ﬁnd the opposite effect. Potentially
therefore, S227 phosphorylation uncouples these activities and
shifts the balance towards substrate ubiquitination.
Why would PI3K, a growth- and survival-promoting kinase,
stimulate activity of a tumor suppressor protein like Fbw7? It
is possible that Fbw7 phosphorylation at S227 balances the
abundance and activity of different Fbw7 substrates and the
net result contributes to the stimulation of growth or survivalby PI3K. On the other hand, some Fbw7 substrates may become
dominant effectors of this phosphorylation event and largely de-
ﬁne the functional outcome. For instance, Fbw7 substrates Myc
and Jun are potent inducers of apoptosis and their downregula-
tion should abate cell death, consistent with a key role of PI3K in
cell survival. In particular, PI3K has been implicated in collabo-
rating with Myc in lymphomagenesis by preventing Myc-in-
duced apoptosis [23].
Myc-induced apoptosis requires high levels of the protein,
and lowering Myc levels promotes proliferation without inducing
cell death [24]. Moreover, the phosphorylation of Myc at T58 is
not only required for recognition by Fbw7, but also for Myc-
dependent apoptosis [25]. Thus, activation of PI3K simulta-
neously provides two signals to directly block Myc-driven cell
death – it inhibits GSK3 to prevent conversion of Myc to its
pro-apoptotic form and stimulates Fbw7’s activity to rapidly de-
grade existing T58-phosphorylated, pro-apoptotic Myc protein
(Fig. 2C).
Because the S227A mutation attenuates but does not abolish
activity of Fbw7 (Fig. 2), it is possible that stimulation of Fbw7
by PI3K is only required to block certain functions of its substrates.
Consistent with this interpretation, RQ PCR analysis showed that
phosphorylation of S227 is required to suppress expression of a
subset of Myc target genes. It appears that regulation of individual
genes requires different Myc levels and PI3K-resistant Fbw7 is able
to downregulate Myc and antagonize transactivation/repression of
some but not all of Myc targets. In summary, we suggest that PI3K
modulates Fbw7’s function to selectively enhance degradation of
its substrates and ﬁne-tune their activity.
Fig. 4. Phosphorylation of Fbw7 is required for its biological activity. (A) Fbw7/ HCT116 cells transduced with retroviruses encoding FLAG-tagged Fbw7 wildtype, the
S227A mutant Fbw7 or a control vector were cultured in medium with 10% FBS (graph on the left) or starved in medium with 0.05% FBS (graph on the right). After 48 h of
serum deprivation, cells were ﬁxed in ethanol, stained with propidium iodide and analyzed by FACS analysis. The experiments shown have been repeated twice with identical
results. (B) Relative mRNA levels of Fbw7/ HCT116 cells transduced as above were assessed by RQ PCR. Left panel shows expression levels of FBXW7mRNA, as well as Fbw7
and Myc protein levels. In the right panel, relative mRNA levels of Myc target genes are shown. Error bars indicate s.d. for technical triplicates.
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